NCT00048035View on ClinicalTrials.gov

A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Anemia

Interventions

DRUG

methoxy polyethylene glycol-epoetin beta [Mircera]

Differing doses and frequencies of iv administration

Trial Locations (14)

10128

New York

11203

Brooklyn

11501

Mineola

26506

Morgantown

35211

Birmingham

37232

Nashville

48236

Detroit

55430

Brooklyn Center

60153

Maywood

89106

Las Vegas

90095

Los Angeles

40202-1718

Louisville

48202-2689

Detroit

07503

Paterson

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT00048035 - A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia | Biotech Hunter | Biotech Hunter